You are here: Home > Institute of Excellence (CPD) > Calendar > CPD Events > OKKO Masterclass 360 2019

OKKO Masterclass 360 2019

Date: 17/03/2019

Venue: Brisbane Convention Centre Grey St South Brisbane , QLD, 4101

Provider: OKKO Eye Specialist Centre

Contact: Narelle Murphy, [E] info@okko.com.au, [P] 07 37250222

Learning Objectives

  • Understand the importance and context of glaucoma diagnosis and co-management within the Australian healthcare landscape.
  • Understand key elements and common pitfalls in glaucoma diagnosis.
  • Select appropriate initial management strategies for glaucoma.
  • Understand key factors in glaucoma monitoring.
  • Implement appropriate communication and referral pathways to ensure optimum patient care.
  • Understand the range of corneal ecstatic disorders and their impact on patients
  • Understand the risk factors for corneal ectasia and progression as well as associated conditions
  • Be able to initiate appropriate lifestyle and medical management strategies for corneal ectasia patients
  • Understand the indications for surgical treatments for corneal ectasia
  • How to evaluate a ptosis patient and indications for ptosis repair
  • How to evaluate a dermatochalasis patient and indications for dermatochalsis repair
  • Functional versus. cosmetic blepharoplasty procedures
  • The features of benign versus malignant eyelid lesions
  • Topical and systemic therapeutic considerations involved in oculoplastic eyelid surgery
  • To recognise key features of age-related macular degeneration (AMD) on both clinical examination and diagnostic imaging, and to differentiate this from other macular disease
  • To become familiar with the different stages of AMD according to the Age-Related Eye Disese Study (AREDS) Grading System
  • To become familiar with the different stages of AMD according to the Age-Related Eye Disese Study (AREDS) Grading System
  • To identify the key constituents of the current AREDS2 anti-oxidant formulation and recognising when nutritional supplements might be indicated
  • To have a working understanding of current and future diagnostic and treatment options for AMD
  • How to evaluate currently available the medical evidence for controversial general medical treatments
  • How to evaluate communicate the currently available the medical evidence for controversial general medical treatments to patients
  • To understand the impact of co-existing glaucoma and anterior segment disease on cataract surgery
  • To become familiar with the appropriate use of antivirals in patients with Herpetic eye disease undergoing cataract surgery
  • To understand the impact of corneal ectasia on biometry
  • To be aware of the impact of cosmetic procedures on ocular surface
  • To understand various presentations & management options for ocular surface squamous neoplasias
  • To understand therapeutic and surgical management options for complex glaucomas
  • To understand the nature, complexity and role of the microbiome
  • To understand the role of genes and environment in regulating the ocular microbiome
  • To understand the role of the ocular microbiome in ocular health and disease
  • To understand the role/s of ocular therapeutic agents before, during and after cataract surgery and their influence on the ocular microbiome
  • To understand the benefits of ocular therapeutic agents before, during and after cataract surgery
  • To understand the adverse effects of ocular and systemic therapeutic agents before, during and after cataract surgery

Max points awarded: 22.00

Session Information

Name
Cataract Surgery Challenges Approaching 2020
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.25
Name
Impact of Glaucoma & Anterior Segment Diseases on Cataract Surgery
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.25
Name
Common Eyelid Problems and their Therapeutic Management
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.25
Name
Glaucoma Shared Care: Tips for Safe, Effective Co-management
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.25
Name
A Matter of Drusen
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.25
Name
Current Controversies in Evidence-based Consumer Health Care and the Advocacy Role of the Allied Health Care Practitioner
Activity Type
Face to Face without Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
1.00
Name
Q&A session – The Microbiome and Ocular Health & Disease
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
3.00
Name
Challenging Glaucoma & Anterior Segment Cases
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
3.00
Name
Corneal Ectasia: Modern Management of a Widening Array of Indications
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
2.25
Name
Glaucoma Australia Update
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
1.50

NameActivity TypeTherapeutic?Manufacturer/
Supplier?
Points for attending &
Passing Assessment
Cataract Surgery Challenges Approaching 2020 Face to Face with AssessmentYesNo2.25
Impact of Glaucoma & Anterior Segment Diseases on Cataract SurgeryFace to Face with AssessmentYesNo2.25
Common Eyelid Problems and their Therapeutic Management Face to Face with AssessmentYesNo2.25
Glaucoma Shared Care: Tips for Safe, Effective Co-managementFace to Face with AssessmentYesNo2.25
A Matter of Drusen Face to Face with AssessmentYesNo2.25
Current Controversies in Evidence-based Consumer Health Care and the Advocacy Role of the Allied Health Care PractitionerFace to Face without AssessmentYesNo1.00
Q&A session – The Microbiome and Ocular Health & DiseaseFace to Face with AssessmentYesNo3.00
Challenging Glaucoma & Anterior Segment CasesFace to Face with AssessmentYesNo3.00
Corneal Ectasia: Modern Management of a Widening Array of IndicationsFace to Face with AssessmentYesNo2.25
Glaucoma Australia Update Face to Face with AssessmentYesNo1.50